FIT-AD SMART Trial is a 12-month study that is testing the impact of various exercise types on cognitive and physical outcomes in older
adults with early-stage Alzheimer's disease. A study partner is required to report on quality-of-life measures.
FIT-AD SMART Trial is a 12-month study that is testing the impact of various exercise types on cognitive and physical outcomes in older
adults with early-stage Alzheimer's disease. A study partner is required to report on quality-of-life measures.
This study is designed as a longitudinal study. It includes surveying current caregivers to assess if they witness lucid moments in a person with Alzheimer’s disease or related dementia. Assessments will be done monthly for one year.
The Learning from Family and Friends Who Helped with Dementia Care Study is seeking former dementia caregivers to learn from their experience with the hope of sharing successful strategies with others.
The Learning Skills Together study is a Zoom-delivered complex care training for family caregivers to persons living with dementia.
The overall goal of this NIH funded project is to adapt a validated digital health intervention called Medication Education, Decision Support, Reminding, and Monitoring (MEDSReM) system (IRB: 22546), currently designed to improve hypertension medication adherence in cognitively normal older adults, to support self-management of hypertension medication for persons with mild cognitive impairment (PwMCI).
MindCrowd is a first-of-its-kind web-based memory study to identify cognitive performance outliers and to better understand their genetic differences. In Phase I, the goal is to have 1 million individuals, aged 18+, take the 10-minute online test and gather information for a more detailed Phase II study.
The National Institute of Aging (NIA) - Family Based Study - Early Onset Alzheimer’s Disease (FBS EOAD) is a study to understand the genetic factors influencing early-onset Alzheimer disease (EOAD) risk. The study includes individuals with EOAD, mild cognitive impairment, or other dementias. The study also recruits additional family members without dementia or memory problems that are willing to participate.
The POLARIS-AD clinical research study is for people who have early symptoms of Alzheimer’s disease and mild cognitive impairment. The study will test a new investigational medication to learn if it can slow or reverse early symptoms of Alzheimer’s disease.